Search Within

Mark Kris

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (43)
  2. Meeting Abstract (40)
  3. Research Letter (1)
Groups
  1. Department of Medicine (84)
  2. Population Sciences Research Program (84)
  3. Solid Tumor Oncology Division (84)
  4. Thoracic Oncology (84)
  5. Epidemiology and Biostatistics (72)
  6. Biostatistics Service (61)

More Groups

People
  1. Ronglai Shen (39)
  2. Marc Ladanyi (24)
  3. Gregory Riely (21)
  4. Charles Rudin (19)
  5. Valerie Rusch (19)
  6. Bernard Park (14)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Journal of Thoracic Oncology (16)
  3. Clinical Cancer Research (7)
  4. Cancer (2)
  5. Cancer Discovery (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Elsevier Inc. (18)
  3. American Association for Cancer Research (11)
  4. Oxford University Press (4)
  5. Elsevier Science, Inc. (3)
  6. Springer (3)

More Publishers

Results (84)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer
    Meeting Abstract

    Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: A retrospective study
    Journal Article

    Zauderer, M. G.; Martin, A.; Egger, J.; Rizvi, H.; Offin, M.; Rimner, A.; Adusumilli, P. S.; Rusch, V. W.; Kris, M. G.; Sauter, J. L.; more...
    The Lancet Digital Health (2021)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers and MET inhibitor resistance
    Journal Article

    Guo, R.; Offin, M.; Brannon, A. R.; Chang, J.; Chow, A.; Delasos, L.; Girshman, J.; Wilkins, O.; McCarthy, C. G.; Makhnin, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save